System and process for purification of Astatine-211 from target materials
Patent
·
OSTI ID:1998263
A new column-based purification system and approach are described for rapid separation and purification of the alpha-emitting therapeutic radioisotope 211At from dissolved cyclotron targets that provide highly reproducible product results with excellent 211At species distributions and high antibody labeling yields compared with prior art manual extraction results of the prior art that can be expected to enable enhanced production of purified 211At isotope products suitable for therapeutic medical applications such as treatment of cancer in human patients.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- Assignee:
- Battelle Memorial Institute (Richland, WA)
- Patent Number(s):
- 11,621,097
- Application Number:
- 17/586,647
- OSTI ID:
- 1998263
- Country of Publication:
- United States
- Language:
- English
Similar Records
System and process for purification of astatine-211 from target materials
Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
A Solid-State Support for Separating Astatine-211 from Bismuth
Patent
·
Mon Feb 21 23:00:00 EST 2022
·
OSTI ID:1892645
Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
Journal Article
·
Fri Dec 14 23:00:00 EST 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23105667
A Solid-State Support for Separating Astatine-211 from Bismuth
Journal Article
·
Fri Apr 17 00:00:00 EDT 2020
· Inorganic Chemistry
·
OSTI ID:1688758